Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan

Conclusions:
The prompt and correct recognition of MG following treatment with immune checkpoint inhibitors in patients with cancer is important.

Source: Neurology - September 11, 2017 Category: Neurology Authors: Suzuki, S., Ishikawa, N., Konoeda, F., Seki, N., Fukushima, S., Takahashi, K., Uhara, H., Hasegawa, Y., Inomata, S., Otani, Y., Yokota, K., Hirose, T., Tanaka, R., Suzuki, N., Matsui, M. Tags: Autoimmune diseases, Myasthenia, Muscle disease, Incidence studies ARTICLE Source Type: research